Skip to main content

Advertisement

Log in

Opioid-Induced Esophageal Dysfunction: An Emerging Entity with Sweeping Consequences

  • Invited Commentary
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Abstract

Adverse effects of opioids on the gastrointestinal tract are well known. However, with the rising epidemic of opioids, its detrimental effects on esophageal physiology are now being increasingly recognized. In this commentary, we briefly review the current evidence behind opioid-induced esophageal dysfunction with potential pathophysiology and treatment options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References and Recommended Reading

  1. Vowles KE, McEntee ML, Julnes PS, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156:569–76.

    Article  Google Scholar 

  2. Choung RS, Locke GR 3rd, Zinsmeister AR, et al. Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study. Am J Gastroenterol. 2009;104:1199–204.

    Article  CAS  Google Scholar 

  3. Gomes T, Tadrous M, Mamdani MM, et al. The burden of opioid-related mortality in the United States. JAMA Network Open. 2018;1:e180217.

    Article  Google Scholar 

  4. Camilleri M, Lembo A, Katzka DA. Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits. Clin Gastroenterol Hepatol. 2017;15:1338–49.

    Article  CAS  Google Scholar 

  5. Camilleri M. Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol. 2011;106:835–42.

    Article  CAS  Google Scholar 

  6. Dowlatshahi K, Evander A, Walther B, et al. Influence of morphine on the distal oesophagus and the lower oesophageal sphincter--a manometric study. Gut. 1985;26:802–6.

    Article  CAS  Google Scholar 

  7. Penagini R, Bianchi PA. Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation. Gastroenterology. 1997;113:409–14.

    Article  CAS  Google Scholar 

  8. Kraichely RE, Arora AS, Murray JA. Opiate-induced oesophageal dysmotility. Aliment Pharmacol Ther. 2010;31:601–6.

    Article  CAS  Google Scholar 

  9. Penagini R, Picone A, Bianchi PA. Effect of morphine and naloxone on motor response of the human esophagus to swallowing and distension. Am J Physiol. 1996;271:G675–80.

    CAS  PubMed  Google Scholar 

  10. Gonzalez ES, Bellver VO, Jaime FC, et al. Opioid-induced lower esophageal sphincter dysfunction. J Neurogastroenterol Motil. 2015;21:618–20.

    Article  Google Scholar 

  11. Ratuapli SK, Crowell MD, DiBaise JK, et al. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110:979–84.

    Article  CAS  Google Scholar 

  12. Savilampi J, Magnuson A, Ahlstrand R. Effects of remifentanil on esophageal motility: a double-blind, randomized, cross-over study in healthy volunteers. Acta Anaesthesiol Scand. 2015;59:1126–36.

    Article  CAS  Google Scholar 

  13. Ravi K, Murray JA, Geno DM, et al. Achalasia and chronic opiate use: innocent bystanders or associated conditions? Dis Esophagus. 2016;29:15–21.

    Article  CAS  Google Scholar 

  14. Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil. 2004;16(Suppl 2):17–28.

    Article  Google Scholar 

  15. Sternini C, Patierno S, Selmer IS, et al. The opioid system in the gastrointestinal tract. Neurogastroenterol Motil. 2004;16(Suppl 2):3–16.

    Article  Google Scholar 

  16. Pasternak GW. Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol. 1993;16:1–18.

    Article  CAS  Google Scholar 

  17. Greenwald MK, Stitzer ML, Haberny KA. Human pharmacology of the opioid neuropeptide dynorphin A(1–13). J Pharmacol Exp Ther. 1997;281:1154–63.

    CAS  PubMed  Google Scholar 

  18. Bagnol D, Mansour A, Akil H, et al. Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract. Neuroscience. 1997;81:579–91.

    Article  CAS  Google Scholar 

  19. Rattan S, Goyal RK. Identification and localization of opioid receptors in the opossum lower esophageal sphincter. J Pharmacol Exp Ther. 1983;224:391–7.

    CAS  PubMed  Google Scholar 

  20. Scarpellini E, Pauwels A, Vos R, et al. Effect of methylnaltrexone and naloxone on esophageal motor function in man. Neurogastroenterol Motil. 2017;29.

    Article  Google Scholar 

  21. Kahrilas PJ, Bredenoord AJ, Carlson DA, et al. Advances in management of esophageal motility disorders. Clin Gastroenterol Hepatol 2018.

  22. Ortiz V, Garcia-Campos M, Saez-Gonzalez E, et al. A concise review of opioid-induced esophageal dysfunction: is this a new clinical entity?. Dis Esophagus 2018;31.

Download references

Author information

Authors and Affiliations

Authors

Contributions

DP, drafting of manuscript and acquisition of data and MV, acquisition of data and critical revision of the manuscript.

Corresponding author

Correspondence to Dhyanesh Patel MD.

Ethics declarations

Conflict of interest

Dhyanesh Patel declares that he has no conflict of interest. Michael Vaezi declares that he has no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patel, D., Vaezi, M. Opioid-Induced Esophageal Dysfunction: An Emerging Entity with Sweeping Consequences. Curr Treat Options Gastro 16, 616–621 (2018). https://doi.org/10.1007/s11938-018-0210-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-018-0210-2

Keywords

Navigation